Answers are grounded in this paper and cite their sources.
// Stefan Wiehr 1 , Philipp Warnke 2,7 , Anna-Maria Rolle 1 , Monika Schütz 2 , Philipp Oberhettinger 2 , Ursula Kohlhofer 3 , Leticia Quintanilla-Martinez 3 , Andreas Maurer 1 , Christopher Thornton 4 , Frederic Boschetti 5 , Gerald Reischl 1 , Ingo B. Autenrieth 2 , Bernd J. Pichler 1 and Stella E. Autenrieth 6 1 Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany 2 Institute of Medical Microbiology and Hygiene, Eberhard Karls University, Tübingen, Germany 3 Institute of Pathology, Eberhard Karls University Tübingen, Tübingen, Germany 4 Biosciences and ISCA Diagnostics Ltd., University of Exeter, Exeter, United Kingdom 5 CheMatech, Faculté des Sciences Mirande, Dijon, France 6 Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany 7 Institute of Medical Microbiology, Virology and Hygiene, Rostock University Hospital, Rostock, Germany Correspondence to: Stella E. Autenrieth, email: // Keywords : bacteria, PET/MR, in vivo imaging, 64Cu, antibody, Immunology and Microbiology Section, Immune response, Immunity Received : October 01, 2015 Accepted : February 20, 2016 Published : February 26, 2016 Abstract The specific and rapid detection of Enterobacteriaceae, the most frequent cause of gram-negative bacterial infections in humans, remains a major challenge. We developed a non-invasive method to rapidly detect systemic Yersinia enterocolitica infections using immunoPET (antibody-targeted positron emission tomography) with [ 64 Cu]NODAGA-labeled Yersinia -specific polyclonal antibodies targeting the outer membrane protein YadA. In contrast to the tracer [ 18 F]FDG, [ 64 Cu]NODAGA-YadA uptake co-localized in a dose dependent manner with bacterial lesions of Yersinia -infected mice, as detected by magnetic resonance (MR) imaging. This was accompanied by elevated uptake of [ 64 Cu]NODAGA-YadA in infected tissues, in ex vivo biodistribution studies, whereas reduced uptake was observed following blocking with unlabeled anti-YadA antibody. We show, for the first time, a bacteria-specific, antibody-based, in vivo imaging method for the diagnosis of a Gram-negative enterobacterial infection as a proof of concept, which may provide new insights into pathogen-host interactions.
No takes yet. Share an insight, caveat, or question.
Wiehr et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: